For a biopharmaceutical industrial revolution to progress and achieve its objectives, there must be convergence, adoption, and integration of enabling technologies, like the Brooks Instrument Biotech Mass Flow Controller, within bioprocess equipment in order to raise operational efficiency, improve quality, and increase drug product yields.

Knowledge management, proper equipment design and stakeholder cooperation are fundamentally necessary to transform Biopharma 4.0 potential into reality. Read this white paper from Brooks Instrument to discover the convergence of data and process to knock down silos and build plant-wide, meaningful IIoT.